The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: A role for Vif in determining virus host range and cross-species transmission

EMBO Journal

Volumn 17, Issue 5, 1998, Pages 1259-1267

  Simon, James H M ^a   Miller, David L ^a   Fouchier, Ron A M ^a   Soares, Marcelo A ^b   Peden, Keith W C ^c   Malim, Michael H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b University of Alabama at Birmingham   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

HIV; SIV; Vif; Viral infection; Zoonosis

Indexed keywords

VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CERCOPITHECIDAE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; SPECIES DIFFERENCE; VIRION; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS TRANSMISSION; ZOONOSIS;

ANIMALS; CELL LINE; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; GENE PRODUCTS, VIF; HUMANS; LENTIVIRUS INFECTIONS; LENTIVIRUSES, PRIMATE; LEUKEMIA VIRUS, MURINE; LEUKOCYTES, MONONUCLEAR; SPECIES SPECIFICITY; T-LYMPHOCYTES; VIRUS REPLICATION;

ANIMALIA; CERCOPITHECIDAE; CERCOPITHECUS AETHIOPS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; MURINAE; MURINE LEUKEMIA VIRUS; PRIMATES; RNA VIRUSES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0032473418     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/17.5.1259     Document Type: Article

References (52)

1. Arthur,L.O., Bess,J.W.Jr, Sowder.R.C.,II, Benveniste.R.E., Mann,D.L., Chermann,J.C. and Henderson,L.E. (1992) Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines, Science, 258, 1935-1938.
2. Bolognesi,D.P, Montelaro.R.C., Frank,H. and Schafer, W. (1978) Assembly of type C oncornaviruses: a model. Science, 199, 183-186.
3. Borman, A.M., Quillent,C, Chameau,P., Dauguet,C. and Clavel,F (1995) Human immunodeficiency virus type 1 Vif mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity. J. Virol., 69, 2058-2067.
4. Bouyac,M., Rey,F., Nascimbeni,M., Courcoul,M., Sire,J., Blanc,D., Clavel,F., Vigne,R. and Spire,B. (1997) Phenotypically Vif human immunodeficiency virus type 1 is produced by chronically infected restrictive cells. J. Virol., 71, 2473-2477.
5. Camaur,D. and Trono,D. (1996) Characterization of human immunodeficiency virus type 1 Vif panicle incorporation. J. Virol., 70, 6106-6111.
6. Courcoul,M, Patience,C., Rey,F., Blanc,D., Harmache,A., Sire,J., Vigne,R. and Spire,B. (1995) Peripheral blood mononuclear cells produce normal amounts of defective Vif human immunodeficiency virus type 1 particle which are restricted for the preretrotranscription steps. J. Virol., 69, 2068-2074.
7. Fan,L. and Peden,K. (1992) Cell-free transmission of Vif mutants of HIV-1. Virology, 190, 19-29.
8. Felber,B.K. and Pavlakis,G.N. (1988) A quantitative bioassay for HIV-1 based on trans-activation. Science, 239, 184-187.
9. Fine,D. and Schochetman,G. (1978) Type D primate retroviruses: a review. Cancer Res., 38, 3123-3139.
10. Fisher,A.G., Ensoli,B., Ivanoff,L., Chamberlain,M., Petteway,S., Ratner,L., Gallo,R.C. and Wong-Staal,F. (1987) The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science, 237, 888-893.
11. Fouchier,R.A.M., Simon,J.H.M., Jaffe,A.B. and Malim,M.H. (1996) Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol- and env-encoded proteins, J. Virol., 70, 8263-8269.
12. Fouchier,R.A.M., Meyer,B.E., Simon,J.H.M., Fischer,U. and Malim,M.H. (1997) HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import. EMBO J., 16, 4531-4539.
13. + T lymphocytes. J. Virol, 66, 6489-6495.
14. Gabuzda,D.H., Li,H., Lawrence,K., Vasir,B.S., Crawford,K. and Langhoff,E. (1994) Essential role of vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocyte/ macrophages. J. AIDS, 7, 908-915.
15. Gelderblom,H.R. (1991) Assembly and morphology of HIV: potential effect of structure on viral function. AIDS, 5, 617-638.
16. mac mutants with deletions in 'nonessential' genes. AIDS Res. Hum. Retroviruses, 10, 607-616.
17. Goff.S., Traktman,P. and Baltimore,D. (1981) Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase. J. Virol, 38, 239-248.
18. Goncalves,J., Korin,Y., Zack,J. and Gabuzda,D. (1996) Role of Vif in human immunodeficiency virus type 1 reverse transcription. J. Virol., 70, 8701-8709.
19. Göttlinger,H.G., Sodroski,J.G. and Haseltine.W.A. (1989) Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA, 86, 5781-5785.
20. Harmache,A. et al. (1996) Requirement of caprine arthritis encephalitis virus vif gene for in vivo replication. Virology, 224, 246-255.
21. Hirsch,V.M. et al. (1993) A distinct African lentivirus from Sykes' monkeys. J. Virol., 67, 1517-1528.
22. Höglund,S., Öhagen,A., Lawrence,K. and Gabuzda,D. (1994) Role of vif during packing of the core of HIV-1. Virology, 201, 349-355.
23. Hunter,E. (1994) Macromolecular interactions in the assembly of HIV and other retroviruses. Semin. Virol., 5, 71-83.
24. Jin,M,J. et al. (1994) Mosaic genome structure of simian immunodeficiency virus from West African green monkeys. EMBO J., 13, 2935-2947.
25. Karczewski,M.K. and Strebel,K. (1996) Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein. J. Virol., 70, 494-507.
26. Liu,H., Wu,X., Newman,M., Shaw,G.M., Hahn,B.H. and Kappes,J.C. (1995) The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures. J. Virol, 69, 7630-7638.
27. Malim,M.H., Hauber,J., Fenrick,R. and Cullen,B.R. (1988) Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes. Nature, 335, 181-183.
28. MiIler,A.D., Law,M-F. and Verma,I.M. (1985) Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene. Mol. Cell. Biol., 5, 431-137.
29. Oberste,M.S. and Gonda,M.A. (1992) Conservation of amino-acid sequence motifs in lentivirus Vif proteins. Virus Genes, 6, 95-102.
30. Ochsenbauer,C., Wilk,T. and Bosch,V. (1997) Analysis of vif-defective human immunodeficiency virus type 1 (HIV-1) virions synthesized in 'non-permissive' T lymphoid cells stably infected with selectable HIV-1. J. Gen. Virol., 78, 627-635.
31. Planelles,V., Jowett,J.B.M., Li,Q.-X., Xie,Y., Hahn,B- and Chen,I.S.Y. (1996) Vpr-induced cell cycle arrest is conserved among primate lentiviruses. J. Virol., 70, 2516-2524.
32. Reddy,T.R., Kraus,G., Yamada,O., Looney,D.J., Suhasini,M. and Wong-Staal,F. (1995) Comparative analyses of human immunodeficiency virus type 1 (HIV-1) and HIV-2 Vif mutants. J. Virol., 69, 3549-3553.
33. Rhee,S.S. and Hunter,E. (1990) A single amino acid substitution within the matrix protein of a type D retrovirus converts its morphogenesis to that of a type C retrovirus. Cell, 63, 77-86.
34. Ryan-Graham,M.A. and Peden,K.W.C. (1995) Both virus and host components are important for the manifestation of a Nef phenotype in HIV-1 and HIV-2. Virology, 213, 158-168.
35. Sakai,H., Shibata.R., Sakuragi,J.-I., Sakuragi,S., Kawamura,M. and Adachi,A. (1993) Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles. J. Virol., 67, 1663-1666.
36. AGM in relation to other primate lentiviruses. Virology, 185, 455-459.
37. Sharp,P.M, Robertson,D.L., Gao,F. and Hahn,B.H. (1994) Origins and diversity of human immunodeficiency viruses. AIDS, 8, S27-S42.
38. Sharp,P.M., Robertson,D.L. and Hahn,B.H. (1995) Cross-species transmission and recombination of 'AIDS' viruses. Philos. Trans. R. Soc. Lond., 349, 41-47.
39. Simon,J.H.M and Malim,M.H. (1996) The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes. J. Virol., 70, 5297-5305.
40. Simon,J.H.M., Southerling,T.E., Peterson,J.C., Meyer,B.E. and Malim,M.H. (1995) Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes. J. Virol., 69, 4166-4172.
41. Simon,J.H.M., Fouchier,R.A.M., Southerling,T,E., Guerra,C.B., Grant,C.K. and Malim,M.H. (1997) The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells. J. Virol., 71, 5259-5267.
42. AGM from tantalus monkeys. Virology, 228, 394-399.
43. Soneoka,Y., Cannon, P.M., Ramsdale, E.E., Griffiths, J.C., Romano,G., Kingsman, S.M. and Kingsman, A.J. (1995) A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res., 23, 628-633.
44. Sova,P. and Volsky, D.J. (1993) Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1. J. Virol., 67, 6322-6326.
45. Spearman,P., Wang,J.-J., Heyden,N.V. and Ratner,L. (1994) Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J. Virol., 68, 3232-3242.
46. Stivahtis,G.L., Soares,M.A., Vodicka,M.A., Hahn,B.H. and Emerman,M. (1997) Conservation and host specificity of Vpr-mediated cell cycle arrest suggest a fundamental role in primate lentivirus evolution and biology. J. Virol, 71, 4331-4338.
47. Tomonaga,K. et al. (1992) Identification of a feline immunodeficiency virus gene which is essential for cell-free virus infectivity. J. Virol., 66, 6181-6185.
48. von Schwedler,U., Song,J., Aiken,C. and Trono,D. (1993) vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol., 67, 4945-4955.
49. Wang, C.-T. and Barklis,E. (1993) Assembly, processing, and infectivity of human immunodeficiency virus type 1 Gag mutants. J. Virol., 67, 4264-4273.
50. Wieland,U., Hartmann,J., Suhr,H., Salzberger,B., Eggers,H.J. and Kühn,J.E. (1994) In vivo genetic variability of the HIV-1 vif gene. Virology, 203, 43-51.
51. Yuan,X., Yu,X., Lee,T.-H. and Essex,M. (1993) Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor. J. Virol., 67, 6387-6394.
52. Zhou,W., Parent,L.J., Wills,J.W. and Resh,M.D. (1994) Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J. Virol, 68, 2556-2569.